The HeLa cell line was the first immortal human cell line that George Otto Gey, Margaret Gey, and Mary Kucibek first isolated from Henrietta Lacks and developed at The Johns Hopkins Hospital in Baltimore, Maryland, in 1951. An immortal human cell line is a cluster of cells that continuously multiply on their own outside of the human from which they originated. Scientists use immortal human cell lines in their research to investigate how cells function in humans. Though the HeLa cell line has contributed to many advancements in biomedical research since the twentieth century, its usage in medical research has been controversial because Lacks did not consent to having her cells used for such purposes. As of 2020, scientists continue to use the HeLa cell line for numerous scientific advancements, such as the development of vaccines and the identification of many underlying disease mechanisms.
Details
- HeLa Cell Line
- Nott, Rohini (Author)
- Darby, Alexis (Editor)
- Arizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia. (Publisher)
- Arizona Board of Regents (Publisher)
- HeLa Cells
- Continuous cell lines
- Research Ethics
- Informed consent (Medical law)
- Cervix uteri--Cancer
- Tissue culture
- Poliomyelitis vaccine
- Cellular Proliferation
- Cell Death
- Escherichia coli
- Taxol
- Uterine Cervical Neoplasms
- Cervical Cancer
- Human Papillomavirus Vaccines
- Vaccines, Synthetic
- Human Research Subject Protection
- Experiments
- People
- ethics
- Concept
- Technologies
- People
- immortal cell line
- Henrietta Lacks